Sourris KC, Ding Y, Maxwell SS, Al-Sharea A, et al. Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammation. Kidney Int 2023 Dec 5:S0085-2538(23)00756-1. doi: 10.1016/j.kint.2023.
PMID: 38069998